A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer

Gynecologic Oncology

Volumn 124, Issue 2, 2012, Pages 205-209

  Sehouli, Jalid ^a   Alvarez, Ana Maria ^b   Manouchehrpour, Shokoufeh ^c   Ghatage, Prafull ^d   Szczylik, Cezary ^e   Zimmermann, Annamaria ^f   Bauknecht, Thomas ^g   Look, Katherine Y ^f   Oskay Öezcelik, Gultan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Instituto de Oncologia Angel H Roffo   (Argentina)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d TOM BAKER CANCER CENTRE   (Canada)

^e Medical Center of Postgraduate Education   (Poland)

^f ELI LILLY AND COMPANY   (United States)

^g LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

Carboplatin; Pemetrexed; Platinum sensitive ovarian cancer; Primary peritoneal cancer

Indexed keywords

CARBOPLATIN; PEMETREXED;

ADULT; ALOPECIA; ANEMIA; CANCER RECURRENCE; CONFERENCE PAPER; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; NAUSEA; NEUTROPENIA; OVARY CANCER; OVERALL SURVIVAL; PERITONEUM CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SCORING SYSTEM; SENSORY NEUROPATHY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DISEASE-FREE SURVIVAL; FEMALE; GLUTAMATES; GUANINE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; SURVIVAL RATE;

EID: 84856010739     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.09.007     Document Type: Conference Paper

References (21)

1. American Cancer Society Global Cancer Facts & Figures 2007 2007 American Cancer Society Atlanta http://www.cancer.org/acs/groups/content/@nho/ documents/document/globalfactsandfigures2007rev2p.pdf
2. R.F. Ozols, M.A. Bookman, D.C. Connolly, M.B. Daly, A.K. Godwin, and R.J. Schilder Focus on epithelial ovarian cancer Cancer Cell 5 2004 19 24 (Pubitemid 38121593)
3. J. Pfisterer, and J.A. Ledermann Management of platinum-sensitive recurrent ovarian cancer Semin Oncol 33 2 Suppl. 6 2006 S12 S16
4. M.K. Parmar, J.A. Ledermann, N. Colombo, A. du Bois, J.F. Delaloye, and G.B. Kristensen Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial Lancet 361 2003 2099 2106
5. C.M. Baldwin, and C.M. Perry Pemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancer Drugs 69 2009 2279 2302
6. N.J. Vogelzang, J.J. Rusthoven, J. Symanowski, C. Denham, E. Kaukel, and P. Ruffie Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 2003 2636 2644 (Pubitemid 46606305)
7. S. Miotti, M. Bagnoli, F. Ottone, A. Tomassetti, M.I. Colnaghi, and S. Canevari Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines J Cell Biochem 65 1997 479 491 (Pubitemid 27240914)
8. G. Corona, F. Giannini, M. Fabris, G. Toffoli, and M. Boiocchi Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells Int J Cancer 75 1998 125 133 (Pubitemid 28113987)
9. C.H. Takimoto, L.A. Hammond-Thelin, J.E. Latz, L. Forero, M. Beeram, and B. Forouzesh Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer Clin Cancer Res 13 2007 2675 2683 (Pubitemid 46788035)
10. I. Vergote, H. Calvert, M. Kania, C. Kaiser, A.H. Zimmermann, and J. Sehouli A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer Eur J Cancer 45 2009 1415 1423
11. J.C. Ruckdeschel The future role of carboplatin Semin Oncol 21 5 Suppl. 12 1994 114 118 (Pubitemid 24378896)
12. P.A. Bunn Jr. Review of therapeutic trials of carboplatin in lung cancer Semin Oncol 16 2 Suppl. 5 1989 27 33 (Pubitemid 19138343)
13. B. Sorbe, H. Andersson, K. Boman, P. Rosenberg, and M. Kalling Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up Int J Gynecol Cancer 18 2008 803 808 (Pubitemid 352020182)
14. R.F. Ozols, B.N. Bundy, B.E. Greer, J.M. Fowler, D. Clarke-Pearson, and R.A. Burger Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol 21 2003 3194 3200 (Pubitemid 46606249)
15. A. Hughes, P. Calvert, A. Azzabi, R. Plummer, R. Johnson, and J. Rusthoven Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma J Clin Oncol 20 2002 3533 3544
16. J. Sehouli, O. Camara, S. Mahner, T. Bauknecht, W. Lichtenegger, and I. Runnebaum A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer Cancer Chemother Pharmacol 66 2010 861 868
17. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Amer Stat Assoc 53 1958 457 481
18. E. Pujade-Lauraine, U. Wagner, E. Aavall-Lundqvist, V. Gebski, M. Heywood, and P.A. Vasey Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse J Clin Oncol 28 2010 3323 3329
19. U.A. Matulonis, N.S. Horowitz, S.M. Campos, H. Lee, J. Lee, and C.N. Krasner Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer J Clin Oncol 26 2008 5761 5766
20. M. Orlando, M.V. Costanzo, R.D. Chacon, and C.D. Tajer Randomized trials of combination chemotherapy (combo) versus monotherapy (mono) in relapsed ovarian carcinoma (ROC): a meta-analysis of published data J Clin Oncol 25 18S 2007 280s abstr 5524
21. J. Pfisterer, I. Vergote, A. du Bois, and E. Eisenhauer Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer Int J Gynecol Cancer 15 Suppl. 1 2005 36 41 (Pubitemid 40696476)